Accriva Diagnostics, Inc. recalls
5 notices naming Accriva Diagnostics, Inc. as the recalling firm, since January 22, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Accriva Diagnostics, Inc.: Hemochron Jr.
Hazard (FDA): Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may…
FDAMedical devices
Accriva Diagnostics, Inc.: directCHECK ACT-LR whole blood quality control
Hazard (FDA): Assayed Whole blood control contains labeling with incorrect performance range.
FDAMedical devices
Accriva Diagnostics, Inc.: Hemochron Activated Clotting Time Low-Range Test Cuvette
Hazard (FDA): Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling.
FDAMedical devices
Accriva Diagnostics, Inc.: VerifyNow PRUTest Platelet Reactivity Test REF 85225 UDI-DI code: 10711234150078 The…
Hazard (FDA): Due to an device without a premarket clearance being incorrectly package and distributed.
FDAMedical devices
Accriva Diagnostics, Inc.: VerifyNow P2Y12 Platelet Reactivity Test
Hazard (FDA): Platelet Reactivity Test distributed without appropriate US-FDA market clearance; if used healthcare personnel could use the baseline PRUTest measurement prior to initiating drug therapy, and then use the percent…
FDAMedical devices